Home
KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals... Market Share Analysis for July 2026

KalVista is advancing science to empower everyday lives with innovative oral medicines. KalVista’s mission begins with hereditary angioedema, HAE.

Health > Biotechnology and Pharmaceuticals

Domainkalvista.com

Year Founded2004

Employees51 - 200

Annual Revenue$15M - $25M

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. (including company regionals)

kalvista.com

See more website traffic and engagement information

KalVista Pharmaceuticals, Inc. Revenue up to July 2026 is 15M - 25M

revenue generated by KalVista Pharmaceuticals, Inc. top domains

KalVista Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for KalVista Pharmaceuticals, Inc. top domains

kalvista.com15M - 25M

See more with Sales Intelligence

Total visits to KalVista Pharmaceuticals, Inc.'s top domains

Understand KalVista Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kalvista.com9.6K

See more with Sales Intelligence

Avg. visit duration in KalVista Pharmaceuticals, Inc.'s top domains

Analyze KalVista Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kalvista.com00:00:25

See more with Sales Intelligence

Avg. pageviews on KalVista Pharmaceuticals, Inc.'s top domains

See how KalVista Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kalvista.com1.93

See more with Sales Intelligence

KalVista Pharmaceuticals, Inc. top competitors by domain

Top similar sites in July 2026, ranked by their affinity

akebia.comCompany NameAkebia TherapeuticsEmployees201 - 500HQUnited States, Massachusetts, CambridgeAnnual revenue$200M - $500MTotal visits11.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by KalVista Pharmaceuticals, Inc.

These are the website technologies, by industry, used by KalVista Pharmaceuticals, Inc. top domains

Widget (5)

Twemoji

Advertising (4)

Facebook Custom Audiences

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

More Technologies

11

See all

News & Signals from KalVista Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNicole Sweeny leaves KalVista Pharmaceuticals, Inc. as Chief Commercial Officer.Nicole Sweeny, former Chief Commercial Officer of KalVista Pharmaceuticals, was elected to the Board of Directors at the Company's Annual Meeting of Stockholders on June 22, 2026.

NewsKalVista Pharmaceuticals, Inc. is developing portfolio of novel, small molecule protease inhibitors for diseases like hereditary angioedema on Jun 12th '26.* For KalVista (the acquirer): As a private, clinical-stage company, KalVista was developing a portfolio of novel, small molecule protease inhibitors for diseases like hereditary angioedema (HAE).

NewsChiesi Group was planning to acquire KalVista Pharmaceuticals, Inc. for $1.9B on Aug 1st '25.Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech's oral therapy Ekterly to treat severe swelling episodes caused by the rare genetic disorder hereditary angioedema.